Tenofovir Disoproxil Fumarate
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
Aurobindo Pharma Limited
Listed by Quinn Pharmaceuticals
| Dosage form | Tablet, Coated |
|---|---|
| Route | Oral |
| Drug class | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 69076-105 |
| FDA application | ANDA209498 |
| RxNorm concept | 349251 |
| Package sizes listed | 1 |
| Marketed since | January 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Aurobindo Pharma Limited
TENOFOVIR DISOPROXIL FUMARATE Tablets
Chartwell RX, LLC.
Strides Pharma Science Limited
Major Pharmaceuticals
Cipla USA Inc.
Florida Pharmaceutical Products, LLC.
A-S Medication Solutions
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.